Medical Research Center, Hamad Medical Corporation, Doha, Qatar.
Medical Education, Sidra Medicine, Doha, Qatar.
Pediatr Pulmonol. 2022 Jun;57(6):1440-1446. doi: 10.1002/ppul.25914. Epub 2022 Apr 13.
This cross-sectional study aims to utilize the Global Asthma Network (GAN) questionnaires to estimate the prevalence of asthma, allergic rhinitis, and eczema among children in Qatar. The study population was comprised of children ages 6-7 and 13-14 years, along with their parents or guardians. The English and Arabic versions of the GAN questionnaires were used to collect data for this study. A total of 2646 participants were recruited (1210 in the 6-7 years age group and 1436 in the 13-14 years age group), in addition to a total of 3831 parents or guardians. The overall prevalence of diagnosed asthma, lifetime allergic rhinitis, and diagnosed eczema in our study sample were as follows: 34.6%, 30.9%, and 37.4%, respectively. The current study showed an increased prevalence rate of asthma and eczema comparing to previous local estimates. These rates were higher in some cases or comparable in other cases to those found elsewhere. It is recommended that future research focus on studying the various factors contributing to the cases of asthma, allergic rhinitis, and eczema in Qatar. The reporting of this study conforms with the STROBE statement.
本横断面研究旨在利用全球哮喘网络（GAN）问卷评估卡塔尔儿童哮喘、过敏性鼻炎和特应性皮炎的患病率。研究人群包括 6-7 岁和 13-14 岁的儿童及其父母或监护人。本研究使用 GAN 问卷的英文和阿拉伯文版本收集数据。共招募了 2646 名参与者（6-7 岁年龄组 1210 名，13-14 岁年龄组 1436 名），以及 3831 名父母或监护人。在我们的研究样本中，确诊哮喘、终身过敏性鼻炎和确诊特应性皮炎的总体患病率分别为：34.6%、30.9%和 37.4%。与以往的本地估计相比，本研究显示哮喘和特应性皮炎的患病率有所增加。在某些情况下，这些比率较高，而在其他情况下则与其他地方的比率相当。建议未来的研究集中研究导致卡塔尔哮喘、过敏性鼻炎和特应性皮炎的各种因素。本报告符合 STROBE 声明。
